Cases & Deals

  • Home
  • Practices
  • Idenix establishes patent portfolio related to nucleoside analog antiviral drugs

Share

Idenix establishes patent portfolio related to nucleoside analog antiviral drugs

January 2007

Client(s) Idenix Pharmaceuticals, Inc.

Jones Day represents Idenix Pharmaceuticals, Inc. in the management and development of a patent portfolio related to nucleoside analog antiviral drugs.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.